| Sl.No | Chapter Name | MP4 Download |
|---|---|---|
| 1 | Lec 1: Introduction :Genes and Genome Organization | Download |
| 2 | Lec 2: History and Basics of Genetic Engineering | Download |
| 3 | Lec 3: Advantages and Limitations of Genetic Engineering | Download |
| 4 | Lec 4: Breakage of Genomic DNA | Download |
| 5 | Lec 5: Repair of Genomic DNA | Download |
| 6 | Lec 6: Homologous and non homologous recombination | Download |
| 7 | Lec 7: Site specific recombination | Download |
| 8 | Lec 8: Targeted genetic modification - I | Download |
| 9 | Lec 9: Targeted genetic modification - II | Download |
| 10 | Lec 10: Basics of Zinc Finger Nucleases | Download |
| 11 | Lec 11: Design of Zinc Finger Nucleases for genome editing | Download |
| 12 | Lec 12: Applications of Zinc Finger Nucleases - PART A | Download |
| 13 | Lec 13: Applications of Zinc Finger Nucleases - PART B | Download |
| 14 | Lec 14: Basics of TALEN - PART A | Download |
| 15 | Lec 15: Basics of TALEN - PART B | Download |
| 16 | Lec 16: Design of TALEN for genome editing - PART A | Download |
| 17 | Lec 17: Design of TALEN for genome editing - PART B | Download |
| 18 | Lec 18: Application of TALEN - Part A | Download |
| 19 | Lec 19: Application of TALEN - Part B | Download |
| 20 | Lec 20: CRISPR system in bacteria - Part A | Download |
| 21 | Lec 21: CRISPR system in bacteria - Part B | Download |
| 22 | Lec 22: CRISPR/Cas9 in Genome Editing - Part A | Download |
| 23 | Lec 23: CRISPR/Cas9 in Genome Editing - Part B | Download |
| 24 | Lec 24: Applications of CRISPR/Cas9 Part A | Download |
| 25 | Lec 25: Applications of CRISPR/Cas9 Part B | Download |
| 26 | Lec 26: Computational Resources for CRISPR / Cas - Part A | Download |
| 27 | Lec 27: Computational Resources for CRISPR / Cas - Part B | Download |
| 28 | Lec 28: Human cell engineering in diseases : Thalassemia - Part A | Download |
| 29 | Lec 29: Human cell engineering in diseases : Thalassemia - Part B | Download |
| 30 | Lec 30: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part A | Download |
| 31 | Lec 31: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part B | Download |
| 32 | Lec 32: Human cell engineering in diseases : Hemophilia - Part A | Download |
| 33 | Lec 33: Human cell engineering in diseases : Hemophilia - Part B | Download |
| 34 | Lec 34: Animal models - Part A | Download |
| 35 | Lec 35: Animal models - Part B | Download |
| 36 | Lec 36: iPSc models - Part A | Download |
| 37 | Lec 37: iPSc models - Part B | Download |
| 38 | Lec 38: Cancer disease models - Part A | Download |
| 39 | Lec 39: Cancer disease models - Part B | Download |
| 40 | Lec 40: Engineered immune cells for Cancer therapy (I) - Part A | Download |
| 41 | Lec 41: Engineered immune cells for Cancer therapy (I) - Part B | Download |
| 42 | Lec 42: Engineered immune cells for Cancer therapy (II) - Part A | Download |
| 43 | Lec 43: Engineered immune cells for Cancer therapy (II) - Part B | Download |
| 44 | Lec 44: History and Basics - Part A | Download |
| 45 | Lec 45: History and Basics - Part B | Download |
| 46 | Lec 46: Genome editing and personalized therapy | Download |
| 47 | Lec 47: Bioethics and Biosafety - Part A | Download |
| 48 | Lec 48: Bioethics and Biosafety - Part B | Download |
| 49 | Lec 49: Regulatory issues in Genome Editing | Download |
| Sl.No | Chapter Name | English |
|---|---|---|
| 1 | Lec 1: Introduction :Genes and Genome Organization | PDF unavailable |
| 2 | Lec 2: History and Basics of Genetic Engineering | Download Verified |
| 3 | Lec 3: Advantages and Limitations of Genetic Engineering | PDF unavailable |
| 4 | Lec 4: Breakage of Genomic DNA | PDF unavailable |
| 5 | Lec 5: Repair of Genomic DNA | PDF unavailable |
| 6 | Lec 6: Homologous and non homologous recombination | PDF unavailable |
| 7 | Lec 7: Site specific recombination | PDF unavailable |
| 8 | Lec 8: Targeted genetic modification - I | PDF unavailable |
| 9 | Lec 9: Targeted genetic modification - II | PDF unavailable |
| 10 | Lec 10: Basics of Zinc Finger Nucleases | PDF unavailable |
| 11 | Lec 11: Design of Zinc Finger Nucleases for genome editing | PDF unavailable |
| 12 | Lec 12: Applications of Zinc Finger Nucleases - PART A | PDF unavailable |
| 13 | Lec 13: Applications of Zinc Finger Nucleases - PART B | PDF unavailable |
| 14 | Lec 14: Basics of TALEN - PART A | PDF unavailable |
| 15 | Lec 15: Basics of TALEN - PART B | PDF unavailable |
| 16 | Lec 16: Design of TALEN for genome editing - PART A | PDF unavailable |
| 17 | Lec 17: Design of TALEN for genome editing - PART B | PDF unavailable |
| 18 | Lec 18: Application of TALEN - Part A | PDF unavailable |
| 19 | Lec 19: Application of TALEN - Part B | PDF unavailable |
| 20 | Lec 20: CRISPR system in bacteria - Part A | PDF unavailable |
| 21 | Lec 21: CRISPR system in bacteria - Part B | PDF unavailable |
| 22 | Lec 22: CRISPR/Cas9 in Genome Editing - Part A | PDF unavailable |
| 23 | Lec 23: CRISPR/Cas9 in Genome Editing - Part B | PDF unavailable |
| 24 | Lec 24: Applications of CRISPR/Cas9 Part A | PDF unavailable |
| 25 | Lec 25: Applications of CRISPR/Cas9 Part B | PDF unavailable |
| 26 | Lec 26: Computational Resources for CRISPR / Cas - Part A | PDF unavailable |
| 27 | Lec 27: Computational Resources for CRISPR / Cas - Part B | PDF unavailable |
| 28 | Lec 28: Human cell engineering in diseases : Thalassemia - Part A | PDF unavailable |
| 29 | Lec 29: Human cell engineering in diseases : Thalassemia - Part B | PDF unavailable |
| 30 | Lec 30: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part A | PDF unavailable |
| 31 | Lec 31: Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part B | PDF unavailable |
| 32 | Lec 32: Human cell engineering in diseases : Hemophilia - Part A | PDF unavailable |
| 33 | Lec 33: Human cell engineering in diseases : Hemophilia - Part B | PDF unavailable |
| 34 | Lec 34: Animal models - Part A | PDF unavailable |
| 35 | Lec 35: Animal models - Part B | PDF unavailable |
| 36 | Lec 36: iPSc models - Part A | PDF unavailable |
| 37 | Lec 37: iPSc models - Part B | PDF unavailable |
| 38 | Lec 38: Cancer disease models - Part A | PDF unavailable |
| 39 | Lec 39: Cancer disease models - Part B | PDF unavailable |
| 40 | Lec 40: Engineered immune cells for Cancer therapy (I) - Part A | PDF unavailable |
| 41 | Lec 41: Engineered immune cells for Cancer therapy (I) - Part B | PDF unavailable |
| 42 | Lec 42: Engineered immune cells for Cancer therapy (II) - Part A | PDF unavailable |
| 43 | Lec 43: Engineered immune cells for Cancer therapy (II) - Part B | PDF unavailable |
| 44 | Lec 44: History and Basics - Part A | PDF unavailable |
| 45 | Lec 45: History and Basics - Part B | PDF unavailable |
| 46 | Lec 46: Genome editing and personalized therapy | PDF unavailable |
| 47 | Lec 47: Bioethics and Biosafety - Part A | PDF unavailable |
| 48 | Lec 48: Bioethics and Biosafety - Part B | PDF unavailable |
| 49 | Lec 49: Regulatory issues in Genome Editing | PDF unavailable |
| Sl.No | Language | Book link |
|---|---|---|
| 1 | English | Not Available |
| 2 | Bengali | Not Available |
| 3 | Gujarati | Not Available |
| 4 | Hindi | Not Available |
| 5 | Kannada | Not Available |
| 6 | Malayalam | Not Available |
| 7 | Marathi | Not Available |
| 8 | Tamil | Not Available |
| 9 | Telugu | Not Available |